Structural insights into amyloid oligomers of the Parkinson disease-related protein α-synuclein

Journal of Biological Chemistry

Volumn 289, Issue 39, 2014, Pages 26733-26742

  Gallea, J Ignacio ^a   Celej, M Soledad ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

AGGREGATES; DISEASES; GLYCOPROTEINS; PROTEINS; TOXICITY;

INSOLUBLE AGGREGATES; INTERMOLECULAR CONTACTS; INTERMOLECULAR INTERACTIONS; INTERNAL ARCHITECTURE; SPATIAL ARRANGEMENTS; STRUCTURAL INSIGHTS; STRUCTURAL REMODELING; SUPRAMOLECULAR ORGANIZATIONS;

OLIGOMERS;

ALPHA SYNUCLEIN; AMYLOID; OLIGOMER;

ARTICLE; BETA SHEET; CONTROLLED STUDY; FLUORESCENCE ANALYSIS; MOLECULAR INTERACTION; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; CHEMICAL STRUCTURE; CHEMISTRY; HUMAN; PARKINSON DISEASE; PROTEIN MULTIMERIZATION; PROTEIN QUATERNARY STRUCTURE; PROTEIN SECONDARY STRUCTURE;

ALPHA-SYNUCLEIN; AMYLOID; HUMANS; MODELS, MOLECULAR; PARKINSON DISEASE; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, SECONDARY;

EID: 84907571241     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.566695     Document Type: Article

References (50)

1. Lashuel, H. A., Overk, C. R., Oueslati, A., and Masliah, E. (2013) The many faces of α-synuclein: from structure and toxicity to therapeutic target. Nat. Rev. Neurosci. 14, 38-48
2. Olzscha, H., Schermann, S. M., Woerner, A. C., Pinkert, S., Hecht, M. H., Tartaglia, G. G., Vendruscolo, M., Hayer-Hartl, M., Hartl, F. U., and Vabulas, R. M. (2011) Amyloid-like aggregates sequester numerous metastable proteins with essential cellular functions. Cell 144, 67-78
3. Butterfield, S. M., and Lashuel, H. A. (2010) Amyloidogenic protein-membrane interactions: mechanistic insight from model systems. Angew. Chem. Int. Ed. Engl. 49, 5628-5654
4. Morimoto, R. I. (2008) Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging. Genes Dev. 22, 1427-1438
5. Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C. M., and Stefani, M. (2002) Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416, 507-511
6. Frost, B., and Diamond, M. I. (2010) Prion-like mechanisms in neurodegenerative diseases. Nat. Rev. Neurosci. 11, 155-159
7. Bartels, T., Choi, J. G., and Selkoe, D. J. (2011) α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature 477, 107-110
8. Fauvet, B., Mbefo, M. K., Fares, M. B., Desobry, C., Michael, S., Ardah, M. T., Tsika, E., Coune, P., Prudent, M., Lion, N., Eliezer, D., Moore, D. J., Schneider, B., Aebischer, P., El-Agnaf, O. M., Masliah, E., and Lashuel, H. A. (2012)α-Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer. J. Biol. Chem. 287, 15345-15364
9. Esteban-Martín, S., Silvestre-Ryan, J., Bertoncini, C. W., and Salvatella, X. (2013) Identification of fibril-like tertiary contacts in soluble monomeric α-synuclein. Biophys. J. 105, 1192-1198
10. Vilar, M., Chou, H. T., Lührs, T., Maji, S. K., Riek-Loher, D., Verel, R., Manning, G., Stahlberg, H., and Riek, R. (2008) The fold of α-synuclein fibrils. Proc. Natl. Acad. Sci. U.S.A. 105, 8637-8642
11. Heise, H., Hoyer, W., Becker, S., Andronesi, O. C., Riedel, D., and Baldus, M. (2005) Molecular-level secondary structure, polymorphism, and dynamics of full-length α-synuclein fibrils studied by solid-state NMR. Proc. Natl. Acad. Sci. U.S.A. 102, 15871-15876
12. Bousset, L., Pieri, L., Ruiz-Arlandis, G., Gath, J., Jensen, P. H., Habenstein, B., Madiona, K., Olieric, V., Böckmann, A., Meier, B. H., and Melki, R. (2013) Structural and functional characterization of two α-synuclein strains. Nat. Commun. 4, 2575
13. Volles, M. J., Lee, S. J., Rochet, J. C., Shtilerman, M. D., Ding, T. T., Kessler, J. C., and Lansbury, P. T., Jr. (2001) Vesicle permeabilization by protofibrillar α-synuclein: implications for the pathogenesis and treatment of Parkinson's disease. Biochemistry 40, 7812-7819
14. Kim, H. Y., Cho, M. K., Kumar, A., Maier, E., Siebenhaar, C., Becker, S., Fernandez, C. O., Lashuel, H. A., Benz, R., Lange, A., and Zweckstetter, M. (2009) Structural properties of pore-forming oligomers of α-synuclein. J. Am. Chem. Soc. 131, 17482-17489
15. Celej, M. S., Sarroukh, R., Goormaghtigh, E., Fidelio, G. D., Ruysschaert, J. M., and Raussens, V. (2012) Toxic prefibrillar α-synuclein amyloid oligomers adopt a distinctive antiparallel β-sheet structure. Biochem. J. 443, 719-726
16. van Rooijen, B. D., van Leijenhorst-Groener, K. A., Claessens, M. M., and Subramaniam, V. (2009) Tryptophan fluorescence reveals structural features of α-synuclein oligomers. J. Mol. Biol. 394, 826-833
17. Mysling, S., Betzer, C., Jensen, P. H., and Jorgensen, T. J. (2013) Characterizing the dynamics of α-synuclein oligomers using hydrogen/deuterium exchange monitored by mass spectrometry. Biochemistry 52, 9097-9103
18. Masuda, M., Dohmae, N., Nonaka, T., Oikawa, T., Hisanaga, S., Goedert, M., and Hasegawa, M. (2006) Cysteine misincorporation in bacterially expressed human α-synuclein. FEBS Lett. 580, 1775-1779
19. Wu, C. W., and Yarbrough, L. R. (1976) N-(1-pyrene)maleimide: a fluorescent cross-linking reagent. Biochemistry 15, 2863-2868
20. Prendergast, F. G., Meyer, M., Carlson, G. L., Iida, S., and Potter, J. D. (1983) Synthesis, spectral properties, and use of 6-acryloyl-2-dimethylaminonaphthalene (Acrylodan). A thiol-selective, polarity-sensitive fluorescent probe. J. Biol. Chem. 258, 7541-7544
21. Zijlstra, N., Claessens, M. M., Blum, C., and Subramaniam, V. (2014) Elucidating the aggregation number of dopamine-induced α-synuclein oligomeric assemblies. Biophys. J. 106, 440-446
22. Zijlstra, N., Blum, C., Segers-Nolten, I. M., Claessens, M. M., and Subramaniam, V. (2012) Molecular composition of sub-stoichiometrically labeled α-synuclein oligomers determined by single-molecule photobleaching. Angew Chem. Int. Ed. Engl. 51, 8821-8824
23. Thirunavukkuarasu, S., Jares-Erijman, E. A., and Jovin, T. M. (2008) Multiparametric fluorescence detection of early stages in the amyloid protein aggregation of pyrene-labeled α-synuclein. J. Mol. Biol. 378, 1064-1073
24. Fernandez-Escamilla, A. M., Rousseau, F., Schymkowitz, J., and Serrano, L. (2004) Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat. Biotechnol. 22, 1302-1306
25. Maurer-Stroh, S., Debulpaep, M., Kuemmerer, N., Lopez de la Paz, M., Martins, I. C., Reumers, J., Morris, K. L., Copland, A., Serpell, L., Serrano, L., Schymkowitz, J. W., and Rousseau, F. (2010) Exploring the sequence determinants of amyloid structure using position-specific scoring matrices. Nat. Methods 7, 237-242
26. Tartaglia, G. G., and Vendruscolo, M. (2008) The Zyggregator method for predicting protein aggregation propensities. Chem. Soc. Rev. 37, 1395-1401
27. Kyte, J., and Doolittle, R. F. (1982) A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157, 105-132
28. Danzer, K. M., Haasen, D., Karow, A. R., Moussaud, S., Habeck, M., Giese, A., Kretzschmar, H., Hengerer, B., and Kostka, M. (2007) Different species of α-synuclein oligomers induce calcium influx and seeding. J. Neurosci. 27, 9220-9232
29. van Rooijen, B. D., Claessens, M. M., and Subramaniam, V. (2009) Lipid bilayer disruption by oligomeric α-synuclein depends on bilayer charge and accessibility of the hydrophobic core. Biochim Biophys. Acta 1788, 1271-1278
30. Lorenzen, N., Nielsen, S. B., Buell, A. K., Kaspersen, J. D., Arosio, P., Vad, B. S., Paslawski, W., Christiansen, G., Valnickova-Hansen, Z., Andreasen, M., Enghild, J. J., Pedersen, J. S., Dobson, C. M., Knowles, T. P., and Otzen, D. E. (2014) The role of stable α-synuclein oligomers in the molecular events underlying amyloid formation. J. Am. Chem. Soc. 136, 3859-3868
31. Celej, M. S., Caarls, W., Demchenko, A. P., and Jovin, T. M. (2009) A triple emission fluorescent probe reveals distinctive amyloid fibrillar polymorphism of wild-type α-synuclein and its familial Parkinson's disease mutants. Biochemistry 48, 7465-7472
32. Valeur, B. (2001) Molecular Fluorescence: Principles and Applications, 1st Ed., pp. 200-225, Wiley-VCH, Weinheim, Germany
33. Eftink, M. R. (1994) The use of fluorescence methods to monitor unfolding transitions in proteins. Biophys. J. 66, 482-501
34. Bucciantini, M., Calloni, G., Chiti, F., Formigli, L., Nosi, D., Dobson, C. M., and Stefani, M. (2004) Prefibrillar amyloid protein aggregates share common features of cytotoxicity. J. Biol. Chem. 279, 31374-31382
35. Glabe, C. G. (2008) Structural classification of toxic amyloid oligomers. J. Biol. Chem. 283, 29639-29643
36. Bertoncini, C. W., and Celej, M. S. (2011) Small molecule fluorescent probes for the detection of amyloid self-assembly in vitro and in vivo. Curr. Protein Pept Sci. 12, 205-220
37. Krishnan, R., and Lindquist, S. L. (2005) Structural insights into a yeast prion illuminate nucleation and strain diversity. Nature 435, 765-772
38. Campioni, S., Mannini, B., Zampagni, M., Pensalfini, A., Parrini, C., Evangelisti, E., Relini, A., Stefani, M., Dobson, C. M., Cecchi, C., and Chiti, F. (2010) A causative link between the structure of aberrant protein oligomers and their toxicity. Nat. Chem. Biol. 6, 140-147
39. Lamberto, G. R., Binolfi, A., Orcellet, M. L., Bertoncini, C. W., Zweckstetter, M., Griesinger, C., and Fernández, C. O. (2009) Structural and mechanistic basis behind the inhibitory interaction of PcTS on α-synuclein amyloid fibril formation. Proc. Natl. Acad. Sci. U.S.A. 106, 21057-21062
40. Conway, K. A., Harper, J. D., and Lansbury, P. T. (1998) Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease. Nat. Med. 4, 1318-1320
41. Conway, K. A., Lee, S. J., Rochet, J. C., Ding, T. T., Williamson, R. E., and Lansbury, P. T., Jr. (2000) Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to earlyonset Parkinson's disease: implications for pathogenesis and therapy. Proc. Natl. Acad. Sci. U.S.A. 97, 571-576
42. Giasson, B. I., Murray, I. V., Trojanowski, J. Q., and Lee, V. M. (2001) A hydrophobic stretch of 12 amino acid residues in the middle of α-synuclein is essential for filament assembly. J. Biol. Chem. 276, 2380-2386
43. Rao, J. N., Dua, V., and Ulmer, T. S. (2008) Characterization ofα-synuclein interactions with selected aggregation-inhibiting small molecules. Biochemistry 47, 4651-4656
44. Bertoncini, C. W., Jung, Y. S., Fernandez, C. O., Hoyer, W., Griesinger, C., Jovin, T. M., and Zweckstetter, M. (2005) Release of long-range tertiary interactions potentiates aggregation of natively unstructuredα-synuclein. Proc. Natl. Acad. Sci. U.S.A. 102, 1430-1435
45. Dedmon, M. M., Lindorff-Larsen, K., Christodoulou, J., Vendruscolo, M., and Dobson, C. M. (2005) Mapping long-range interactions in α-synuclein using spin-label NMR and ensemble molecular dynamics simulations. J. Am. Chem. Soc. 127, 476-477
46. Lee, J. C., Gray, H. B., and Winkler, J. R. (2005) Tertiary contact formation in α-synuclein probed by electron transfer. J. Am. Chem. Soc. 127, 16388-16389
47. Wu, K. P., and Baum, J. (2010) Detection of transient interchain interactions in the intrinsically disordered protein α-synuclein by NMR paramagnetic relaxation enhancement. J. Am. Chem. Soc. 132, 5546-5547
48. Kaylor, J., Bodner, N., Edridge, S., Yamin, G., Hong, D. P., and Fink, A. L. (2005) Characterization of oligomeric intermediates in α-synuclein fibrillation: FRET studies of Y125W/Y133F/Y136F α-synuclein. J. Mol. Biol. 353, 357-372
49. Yushchenko, D. A., Fauerbach, J. A., Thirunavukkuarasu, S., Jares-Erijman, E. A., and Jovin, T. M. (2010) Fluorescent ratiometric MFC probe sensitive to early stages ofα-synuclein aggregation. J. Am. Chem. Soc. 132, 7860-7861
50. Yap, T. L., Pfefferkorn, C. M., and Lee, J. C. (2011) Residue-specific fluorescent probes of α-synuclein: detection of early events at the N-and C-termini during fibril assembly. Biochemistry 50, 1963-1965